Published in

Springer (part of Springer Nature), Medical Oncology, 2(36), 2019

DOI: 10.1007/s12032-018-1238-9

American Society of Clinical Oncology, Journal of Clinical Oncology, 15_suppl(36), p. e17005-e17005

DOI: 10.1200/jco.2018.36.15_suppl.e17005

Links

Tools

Export citation

Search in Google Scholar

The timing of docetaxel initiation in metastatic castrate sensitive prostate cancer and the rate of chemotherapy induced toxicity.

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO